Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$40.25 - $52.99 $201,250 - $264,950
-5,000 Reduced 19.46%
20,700 $859,000
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $4.46 Million - $5.05 Million
-92,900 Reduced 78.33%
25,700 $1.39 Million
Q4 2023

Feb 01, 2024

BUY
$48.48 - $57.85 $1.66 Million - $1.98 Million
34,300 Added 40.69%
118,600 $6.09 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $1.34 Million - $1.5 Million
-23,200 Reduced 21.58%
84,300 $4.89 Million
Q2 2023

Aug 07, 2023

SELL
$63.71 - $70.74 $1.99 Million - $2.21 Million
-31,300 Reduced 22.55%
107,500 $6.87 Million
Q1 2023

May 08, 2023

BUY
$65.71 - $74.53 $5.44 Million - $6.17 Million
82,800 Added 147.86%
138,800 $9.62 Million
Q4 2022

Feb 01, 2023

BUY
$68.48 - $81.09 $3.83 Million - $4.54 Million
56,000 New
56,000 $4.03 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $6.05 Million - $7.85 Million
124,100 Added 49.11%
376,800 $19.6 Million
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $1.9 Million - $2.15 Million
-34,500 Reduced 12.01%
252,700 $15.7 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $3.59 Million - $4.48 Million
71,100 Added 32.9%
287,200 $15.9 Million
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $3.48 Million - $4.01 Million
58,100 Added 36.77%
216,100 $13.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
158,000
158,000 $8.8 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.